Bajaj Healthcare Ltd
Established in the year 1993, Bajaj Healthcare Ltd is an estalished player in the Indian Pharmacuetical Industry and fastest growing mid-cap pharmaceutical companies in India.[1]
It is a bulk drug manufacturer manufacturing and supply of various Active Pharmaceutical Ingredients (API's), Amino acids and Nutritional supplements for Pharmaceuticals, Neutraceuticals, Food industries. [2]
- Market Cap ₹ Cr.
- Current Price ₹
- High / Low ₹ /
- Stock P/E
- Book Value ₹
- Dividend Yield %
- ROCE %
- ROE %
- Face Value ₹
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Figures in Rs. Crores
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Raw PDF |
Profit & Loss
Figures in Rs. Crores
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Dividend Payout % |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | % |
Balance Sheet
Figures in Rs. Crores
| Equity Capital |
| Reserves |
| Preference Capital |
| Total Liabilities |
| CWIP |
| Investments |
| Total Assets |
Cash Flows
Figures in Rs. Crores
| Net Cash Flow |
Ratios
Figures in Rs. Crores
| Debtor Days |
| Inventory Days |
| Days Payable |
| Cash Conversion Cycle |
| Working Capital Days |
| ROCE % |
Documents
Announcements
-
Compliance Certificate For The Year Ended 31St March, 2024
20 Apr - Compliance Certificate under Reg. 7(3) of LODR Regulations, 2015 for the year ended 31st March, 2024.
- Certificate Under Regulation 40(9) Of SEBI (LODR) Regulations, 2015 For The Year Ended 31St March 2024 17 Apr
- Clarification W.R.T. Increase In Volume Of Shares Of The Company 15 Apr
-
Clarification sought from Bajaj Healthcare Ltd
15 Apr - Exchange has sought clarification from Bajaj Healthcare Ltd on April 15, 2024, with reference to Movement in Volume.
- Shareholder Meeting / Postal Ballot-Outcome of AGM 6 Apr
Annual reports
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
Product Portfolio
The Co. is into manufacturing and supply of API's, Intermediates, Formulations and Impurities. [1]
With 6 API manufacturing facilities spread across different states, API contributes around 90% to the overall revenue mix. It has a strong presence in more than 50 countries through exports of API's with an aggregate manufacturing capacity of 730 MT per month. [2]